Comparative Pharmacology
Head-to-head clinical analysis: OSPEMIFENE versus OSPHENA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSPEMIFENE versus OSPHENA.
OSPEMIFENE vs OSPHENA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ospemifene is a selective estrogen receptor modulator (SERM) that acts as an agonist on estrogen receptors in vaginal tissues, leading to proliferation and maturation of vaginal epithelium, while exhibiting antagonist activity on breast and endometrial tissues.
Selective estrogen receptor modulator (SERM) that acts as an estrogen agonist on bone and lipid metabolism, and as an estrogen antagonist on breast and uterine tissue. It mimics estrogen's effects on bone by reducing bone resorption and increasing bone mineral density.
60 mg orally once daily.
60 mg orally once daily with food.
None Documented
None Documented
Terminal elimination half-life is approximately 26 hours (range 20–30 hours), supporting once-daily dosing.
Clinical Note
moderateOspemifene + Sulfisoxazole
"The serum concentration of Sulfisoxazole can be increased when it is combined with Ospemifene."
Clinical Note
moderateOspemifene + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Ospemifene."
Clinical Note
moderateOspemifene + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Ospemifene."
Clinical Note
moderateOspemifene + Fluconazole
The terminal elimination half-life of ospemifene is approximately 26 hours (range 22-39 hours), supporting once-daily dosing.
Primarily hepatic metabolism with biliary excretion; < 30% renal elimination as metabolites. Fecal excretion accounts for approximately 70% of total clearance.
Following oral administration, 50% of a radiolabeled dose is excreted in urine and 35% in feces within 168 hours, primarily as glucuronide conjugates; <1% is excreted unchanged.
Category C
Category C
Selective Estrogen Receptor Modulator (SERM)
Selective Estrogen Receptor Modulator (SERM)
"The serum concentration of Fluconazole can be increased when it is combined with Ospemifene."